SEC Form 4 research
| Issuer | Monopar Therapeutics |
|---|---|
| Tickers | MNPR |
| Reporting owners | 23 |
| Officers and directors | 9 |
| Last public filing | 2026-10-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-05 | 2026-10-01 | STARR CHRISTOPHER M | S | 799 | $79.67 | Not reported |
| 2026-10-05 | 2026-10-01 | STARR CHRISTOPHER M | S | 2,970 | $78.82 | Not reported |
| 2026-10-05 | 2026-10-01 | STARR CHRISTOPHER M | S | 4,631 | $78.09 | Not reported |
| 2026-09-28 | 2026-09-24 | Robinson Chandler | S | 600 | $89.79 | Not reported |
| 2026-09-28 | 2026-09-24 | Robinson Chandler | S | 8,368 | $88.97 | Not reported |
| 2026-09-28 | 2026-09-24 | Robinson Chandler | S | 9,638 | $87.96 | Not reported |
| 2026-09-28 | 2026-09-24 | Robinson Chandler | S | 10,450 | $87.15 | Not reported |
| 2026-08-28 | 2026-08-26 | Tsuchimoto Kim R | S | 590 | $113.84 | Not reported |
| 2026-08-28 | 2026-08-26 | Tsuchimoto Kim R | S | 602 | $112.93 | Not reported |
| 2026-08-28 | 2026-08-26 | Tsuchimoto Kim R | S | 1,098 | $111.84 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.